Want to see JP:4885 full AI Analyst Report?
4885 Stock Chart & Stats
¥827.00
-¥82.00(-7.25%)
At close: 4:00 PM EST
¥827.00
-¥82.00(-7.25%)
Day’s Range― - ―
52-Week Range¥703.00 - ¥1,380.00
Previous CloseN/A
Volume1.18M
Average Volume (3M)8.80K
Market Cap
¥3.36B
Enterprise Value¥4.19B
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)22.4
Beta0.85
Next Earnings
Oct 09, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield4.25%
Share Statistics
EPS (TTM)-43.53
Shares Outstanding4,095,500
10 Day Avg. Volume6,960
30 Day Avg. Volume8,803
Financial Highlights & Ratios
PEG Ratio-0.75
Price to Book (P/B)1.56
Price to Sales (P/S)0.51
P/FCF Ratio6.97
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Top-line Growth MomentumSustained revenue acceleration into 2026 indicates improved market demand or commercial execution. Strong top-line momentum supports longer-term operating leverage, capacity utilization and investment in product lines, reducing reliance on one-off cost actions over the next several quarters.
Operating And Cash-flow RecoveryImproved operating profitability and a meaningful rebound in operating and free cash flow enhance internal funding for capex, working capital and deleveraging. If sustained, stronger cash generation materially raises strategic flexibility and investment capacity over the medium term.
Larger Equity Base And Serviceable Balance SheetAn expanding equity base provides a durable cushion for funding growth and absorbing shocks. While leverage has risen, stronger equity supports asset-backed investment and preserves credit capacity, helping the firm maintain operations and strategic moves over coming quarters.
Bears Say
Rising LeverageIncreasing reliance on debt reduces financial flexibility and raises interest and refinancing risk. If earnings or cash flow weaken, higher leverage could force tighter capital allocation, slower investment or costly refinancing over the next several quarters.
Compressed Net MarginsFalling net margins suggest non-operating costs, tax or financing pressures are eroding retained profits despite operational gains. Persistently low net margins restrict internal funding for growth and deleveraging, leaving less buffer against cyclical or industry shocks.
Volatile Cash Flow And EarningsMarked swings in free cash flow and sharply negative EPS growth indicate earnings and cash conversion volatility. Such variability undermines predictability of reinvestment and debt servicing, increasing execution risk and complicating multi-quarter planning for investors and management.
4885 FAQ
What was MUROMACHI CHEMICALS INC.’s price range in the past 12 months?
MUROMACHI CHEMICALS INC. lowest stock price was ¥703.00 and its highest was ¥1380.00 in the past 12 months.
What is MUROMACHI CHEMICALS INC.’s market cap?
MUROMACHI CHEMICALS INC.’s market cap is ¥3.36B.
When is MUROMACHI CHEMICALS INC.’s upcoming earnings report date?
MUROMACHI CHEMICALS INC.’s upcoming earnings report date is Oct 09, 2026 which is in 84 days.
How were MUROMACHI CHEMICALS INC.’s earnings last quarter?
MUROMACHI CHEMICALS INC. released its earnings results on Jul 14, 2026. The company reported -¥43.53 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.
Is MUROMACHI CHEMICALS INC. overvalued?
According to Wall Street analysts MUROMACHI CHEMICALS INC.’s price is currently Overvalued.
Does MUROMACHI CHEMICALS INC. pay dividends?
MUROMACHI CHEMICALS INC. pays a Semiannually dividend of ¥13 which represents an annual dividend yield of 4.25%. See more information on MUROMACHI CHEMICALS INC. dividends here
What is MUROMACHI CHEMICALS INC.’s EPS estimate?
MUROMACHI CHEMICALS INC.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does MUROMACHI CHEMICALS INC. have?
MUROMACHI CHEMICALS INC. has 4,095,500 shares outstanding.
What happened to MUROMACHI CHEMICALS INC.’s price movement after its last earnings report?
MUROMACHI CHEMICALS INC. reported an EPS of -¥43.53 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 3.082%.
Which hedge fund is a major shareholder of MUROMACHI CHEMICALS INC.?
Currently, no hedge funds are holding shares in JP:4885
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
MUROMACHI CHEMICALS INC.
Muromachi Chemicals Inc. plans, produces, and distributes pharmaceuticals, health foods, and chemicals in Japan. It offers active pharmaceutical ingredients and intermediate synthesis products; commissioned processing services for pharmaceuticals; and commissioned synthesis services, including GLP analysis, storage, stability testing, and repurification of radioisotopes. The company also provides traditional tablets; jelly; and non-alcoholic beverage products. In addition, it offers ion-exchange resins; separation membranes; water-treatment products; and contract processing services. Further, it provides functional adhesives; product contamination removal and dust removal mats, and antistatic products for use in the electronics industry; and engages in the commissioned manufacturing and processing of functional pastes. The company was founded in 1917 and is headquartered in Omuta, Japan.
Technical Analysis
―
NANKAI CHEMICAL COMPANY LIMITED
―
Toho Acetylene Co., Ltd.
―
Chemipro Kasei Kaisya,Ltd.
―
KNC Laboratories Co.,Ltd.
―